Mark M. Davis
Academic Appointments
- Professor, Microbiology & Immunology
- Member, Bio-X
- Member, Cancer Center
Contact Information
-
Academic Offices
Administrative Contact Barbara Whyte Administrative Assistant Email Tel Work 650-725-4755
Professional Snapshot
Administrative Appointments
- The Burt and Marion Avery Family Professor of Immunology, Stanford University School of Medicine (2007 - present)
- Director, Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine (2004 - present)
- Chair, Stanford University School of Medicine - Microbiology & Immunology (2002 - 2004)
Honors and Awards
- Milton and Francis Clauser Doctoral Prize, Caltech (1981)
- Passano Young Scientist Award, Passano Foundation (1985)
- Eli Lilly Award in Microbiology and Immunology, American Society of Microbiology (1986)
- Howard Taylor Ricketts Award, University of Chicago (1988)
- Gairdner Prize, Gairdner Foundation (1989)
Education & Community
Professional Education
- Ph. D., Caltech, Molecular Biology (1981)
- B.A., The Johns Hopkins University, Molecular Biology (1974)
Postdoctoral Advisees
Peter Ebert, David Furman, Ofir Goldberger, Evan Newell, Fleur Tynan, Jianming Xie
Graduate & Fellowship Program Affiliations
Web Site Links
Scientific Focus
Research Interests
We are interested in the molecular basis of T and B lymphocyte recognition, as well as the control of differentiation and functional responses in these cells. In particular, we have studied the biochemical basis of T cell receptor binding to antigen/MHC complexes and find that the strength of the interactions is a very good predictor of what the resulting T cell response will be. We also find that T cell receptor-peptide/ MHC complexes have an inherent ability to form oligomers and that this could be part of the ‘trigger’ for T cell activation. One spin-off of these biochemical studies has been the development of tetrameric peptide/MHC reagents which have proven to be generally useful for staining and characterizing antigen-specific T cells in complex mixtures of lymphocytes (i.e. McMichael and Callaghan, J. Exp. Med., 187:1367-1371, 1998). Among other things, we have used these tetramers to follow tumor specific T cells in patients with Melanoma and other cancers. In one patient where we see a substantial number of CD8+ T cells specific for a tumor antigen, the cells have no cytolytic activity and thus seem to have been ‘anergized’ by the tumor. We are now working with a number of groups that have developed different vaccination strategies to determine which strategies are best able to produce a useful response.
Another important aspect of T cell recognition that is something of a ‘black box’ is the mystery of what actually happens on the surface of T cell while it is surveying an antigen presenting cell. To investigate this we have made a large series of green fluorescent protein tagged cell surface molecules, expressed them in B or T lymphocytes and followed their movements using multi-color video microscopy. Thus far we find that many key molecules (ICAM-1, CD48, class II, MHC) on the B cell cluster to the interface with a T cell within seconds after the first rise in internal calcium (in the T cell) and the corresponding movement of complimentary membrane...
Publications
- Towards a cytokine-cell interaction knowledgebase of the adaptive immune system. "Pac Symp Biocomput" 2009 : 439-50
- Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. "Nat Methods" 2009 ; 7 497-9
- Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. "Immunity" 2008 ; 1 90-100
- Structural insight into pre-B cell receptor function. "Science" 2007 ; 5822 291-4
- miR-181a is an intrinsic modulator of T cell sensitivity and selection. "Cell" 2007 ; 1 147-61

